Vinge advises Intrum in connection with its EUR 450m bond issuance

Vinge advises Intrum AB (publ) in connection with its issuance of senior secured fixed rate bonds in an amount of EUR 450 million.

The proceeds will be used to refinance, in part, Intrum’s 3.125% Senior Notes due 2024, and the bonds will be listed on the Securities Official List of the Luxembourg Stock Exchange. The bonds have a tenor of five years and were issued with a coupon of 9.25 per cent and at a price of 97.020% of the nominal amount.

Vinge’s team consisted of Louise Brorsson Salomon, Lionardo Ojeda, Jolinn Uhlin, Calle Tengwall Pagels (Banking and Finance), Victor Ericsson and Maja Prahl (Tax)


Vinge advises Spetses Investments and Bacara Holdings on the public offer for IRRAS

A bid consortium, acting through IR Holding Bidco Inc, has announced and completed a public offer to the shareholders of IRRAS AB (publ). The consortium included, among others, IRRAS’ two largest shareholders, Spetses Investments Ltd and Bacara Holdings Limited, both advised by Vinge.
October 03, 2023

Vinge advises SAGA Diagnostics AB on convertible note issue

SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023